Never has a biomarker with so much evidence demonstrating its disutility, enjoyed such a long reign of prosperity as BNP and its natriuretic analogs. And while evidence discrediting BNP's use for the diagnosis and inpatient management of acute exacerbations of heart failure (HF) is well documented, its utility to guide outpatient therapy in patients […]
EMCrit by Rory Spiegel.
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2gcU7RI
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου